Immortalized human hepatic cell lines for in vitro testing and research purposes

Methods in Molecular Biology

Volumn 1250, Issue , 2015, Pages 53-76

  Ramboer, Eva ^a   Vanhaecke, Tamara ^a   Rogiers, Vera ^a   Vinken, Mathieu ^a  

^a NONE

Author keywords

Cell line; Human; Immortalization; Liver

Indexed keywords

CORE PROTEIN; CRE RECOMBINASE; TELOMERASE REVERSE TRANSCRIPTASE; ONCOPROTEIN; TELOMERASE; TERT PROTEIN, HUMAN;

ARTICLE; CELL FUNCTION; CELL IMMORTALIZATION; CELL STIMULATION; GENE CONTROL; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN ARTIFICIAL CHROMOSOME; HUMAN CELL; IMMORTALIZED CELL LINE; IN VITRO STUDY; LIVER CELL; PLASMID TRANSFECTION; PRIORITY JOURNAL; PROMOTER REGION; VIRAL GENE DELIVERY SYSTEM; VIRUS ONCOGENE; CELL CULTURE TECHNIQUE; DRUG EFFECTS; GENETICS; METABOLISM; RESEARCH; TRANSFORMED CELL LINE;

CELL CULTURE TECHNIQUES; CELL LINE, TRANSFORMED; GENE TRANSFER TECHNIQUES; HEPATOCYTES; HUMANS; IN VITRO TECHNIQUES; ONCOGENE PROTEINS, VIRAL; RESEARCH; TELOMERASE;

EID: 84927673763     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-2074-7_4     Document Type: Article

References (136)

1. Hewitt NJ, Lechon MJ, Houston JB et al (2007) Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug Metab Rev 39:159-234
2. Sinz M, Kim S (2006) Stem cells, immortalized cells and primary cells in ADMET assays. Drug Discov Today Technol 3:79-85
3. Soldatow VY, Lecluyse EL, Griffi th LG et al (2013) In vitro models for liver toxicity testing. Toxicol Res 2:23-39
4. Rodrigues RM, De Kock J, Branson S et al (2014) Human skin-derived stem cells as a novel cell source for in vitro hepatotoxicity screening of pharmaceuticals. Stem Cells Dev 23:44-55
5. Allen JW, Bhatia SN (2002) Improving the next generation of bioartifi cial liver devices. Semin Cell Dev Biol 13:447-454
6. Chamuleau RA, Deurholt T, Hoekstra R (2005) Which are the right cells to be used in a bioartifi cial liver? Metab Brain Dis 20: 327-335
7. Brandon EF, Raap CD, Meijerman I et al (2003) An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. Toxicol Appl Pharmacol 189:233-246
8. Choi S, Sainz B, Corcoran P et al (2009)Characterization of increased drug metabolism activity in dimethyl sulfoxide (DMSO)-treated Huh7 hepatoma cells. Xenobiotica 39:205-217
9. Lim PL, Tan W, Latchoumycandane C et al (2007) Molecular and functional characterization of drug-metabolizing enzymes and transporter expression in the novel spontaneously immortalized human hepatocyte line HC-04. Toxicol In Vitro 21:1390-1401
10. Szabo M, Veres Z, Baranyai Z et al (2013) Comparison of human hepatoma HepaRG cells with human and rat hepatocytes in uptake transport assays in order to predict a risk of drug induced hepatotoxicity. PLoS One 8:e59432
11. Aninat C, Piton A, Glaise D et al (2006) Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells. Drug Metab Dispos 34:75-83
12. Guillouzo A, Corlu A, Aninat C et al (2007) The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics. Chem Biol Interact 168:66-73
13. Deurholt T, van Til NP, Chhatta AA et al (2009) Novel immortalized human fetal liver cell line, cBAL111, has the potential to differentiate into functional hepatocytes. BMC Biotechnol 9:89
14. Reid Y, Gaddipati JP, Yadav D et al (2009) Establishment of a human neonatal hepatocyte cell line. In Vitro Cell Dev Biol Anim 45:535-542
15. Clayton RF, Rinaldi A, Kandyba EE et al (2005) Liver cell lines for the study of hepatocyte functions and immunological response. Liver Int 25:389-402
16. Tsuruga Y, Kiyono T, Matsushita M et al (2008) Establishment of immortalized human hepatocytes by introduction of HPV16 E6/ E7 and hTERT as cell sources for liver cellbased therapy. Cell Transplant 17:1083-1094
17. Fukaya K, Asahi S, Nagamori S et al (2001) Establishment of a human hepatocyte line (OUMS-29) having CYP 1A1 and 1A2 activities from fetal liver tissue by transfection of SV40 LT. In Vitro Cell Dev Biol Anim 37:266-269
18. Hariparsad N, Carr BA, Evers R et al (2008) Comparison of immortalized Fa2N-4 cells and human hepatocytes as in vitro models for cytochrome P450 induction. Drug Metab Dispos 36:1046-1055
19. Nguyen TH, Mai G, Villiger P et al (2005) Treatment of acetaminophen-induced acute liver failure in the mouse with conditionally immortalized human hepatocytes. J Hepatol 43:1031-1037
20. Cascio SM (2001) Novel strategies for immortalization of human hepatocytes. Artif Organs 25:529-538
21. Pan X, Li J, Du W et al (2012) Establishment and characterization of immortalized human hepatocyte cell line for applications in bioartifi cial livers. Biotechnol Lett 34:2183-2190
22. Li J, Li LJ, Cao HC et al (2005) Establishment of highly differentiated immortalized human hepatocyte line with simian virus 40 large tumor antigen for liver based cell therapy. ASAIO J 51:262-268
23. Schippers IJ, Moshage H, Roelofsen H et al (1997) Immortalized human hepatocytes as a tool for the study of hepatocytic (de-)differentiation. Cell Biol Toxicol 13:375-386
24. Pfeifer AM, Cole KE, Smoot DT et al (1993) Simian virus 40 large tumor antigenimmortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens. Proc Natl Acad Sci U S A 90:5123-5127
25. Noguchi M, Hirohashi S (1996) Cell lines from non-neoplastic liver and hepatocellular carcinoma tissue from a single patient. In Vitro Cell Dev Biol Anim 32:135-137
26. Zhao L, Li J, Lv G et al (2012) Evaluation of a reversibly immortalized human hepatocyte line in bioartifi cial liver in pigs. Afr J Biotechnol 11:4116-4126
27. Chen Y, Li J, Liu X et al (2010) Transplantation of immortalized human fetal hepatocytes prevents acute liver failure in 90 % hepatectomized mice. Transplant Proc 42:1907-1914
28. Smalley M, Leiper K, Tootle R et al (2001) Immortalization of human hepatocytes by temperature-sensitive SV40 large-T antigen. In Vitro Cell Dev Biol Anim 37:166-168
29. Kobayashi N, Fujiwara T, Westerman KA et al (2000) Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science 287:1258-1262
30. Ilyin G, Rescan C, Rialland M et al (2000) Growth control and cell cycle progression in cultured hepatocytes. In: Edwards A, Berry M (eds) The hepatocyte review. Kluwer Academic, The Netherlands, pp 263-280
31. Runge DM, Runge D, Dorko K et al (1999) Epidermal growth factor-and hepatocyte growth factor-receptor activity in serum-free cultures of human hepatocytes. J Hepatol 30:265-274
32. Ozturk M, Arslan-Ergul A, Bagislar S et al (2009) Senescence and immortality in hepatocellular carcinoma. Cancer Lett 286:103-113
33. Schafer KA (1998) The cell cycle: a review. Vet Pathol 35:461-478
34. Wege H, Le HT, Chui MS et al (2003) Telomerase reconstitution immortalizes human fetal hepatocytes without disrupting their differentiation potential. Gastroenterology 124:432-444
35. Chiu CP, Harley CB (1997) Replicative senescence and cell immortality: the role of telomeres and telomerase. Proc Soc Exp Biol Med 214:99-106
36. Lipps C, May T, Hauser H et al (2013) Eternity and functionality: rational access to physiologically relevant cell lines. Biol Chem 394:1637-1648
37. McLean J (1999) Immortalization Strategies for Mammalian Cells. In: Jenkins N (ed) Animal cell biotechnology: methods and protocols. Humana, Totowa, pp 61-72
38. Noguchi H, Kobayashi N (2013) Controlled expansion of mammalian cell populations by reversible immortalization. J Biotechnol Biomater 3:158
39. Waki K, Anno K, Ono T et al (2010) Establishment of functional telomerase immortalized human hepatocytes and a hepatic stellate cell line for telomere-targeting anticancer drug development. Cancer Sci 101:1678-1685
40. Wege H, Chui MS, Le HT et al (2003) In vitro expansion of human hepatocytes is restricted by telomere-dependent replicative aging. Cell Transplant 12:897-906
41. Curran TR, Bahner RI, Oh W et al (1993) Mitogen-independent DNA synthesis by fetal rat hepatocytes in primary culture. Exp Cell Res 209:53-57
42. Okitsu T, Kobayashi N, Jun HS et al (2004) Transplantation of reversibly immortalized insulin-secreting human hepatocytes controls diabetes in pancreatectomized pigs. Diabetes 53:105-112
43. Totsugawa T, Yong C, Rivas-Carrillo JD et al (2007) Survival of liver failure pigs by transplantation of reversibly immortalized human hepatocytes with tamoxifen-mediated selfrecombination. J Hepatol 47:74-82
44. Lee KM, Choi KH, Ouellette MM (2004) Use of exogenous hTERT to immortalize primary human cells. Cytotechnology 45:33-38
45. Ray RB, Meyer K, Ray R (2000) Hepatitis C virus core protein promotes immortalization of primary human hepatocytes. Virology 271: 197-204
46. Basu A, Meyer K, Ray RB et al (2002) Hepatitis C virus core protein is necessary for the maintenance of immortalized human hepatocytes. Virology 298:53-62
47. Werner A, Duvar S, Müthing J et al (1999) Cultivation and characterization of a new immortalized human hepatocyte cell line, HepZ, for use in an artifi cial liver support system. Ann N Y Acad Sci 875:364-368
48. Wang X, Mani P, Sarkar DP et al (2009) Ex vivo gene transfer into hepatocytes. Methods Mol Biol 481:117-140
49. Kobayashi N, Noguchi H, Watanabe T et al (2001) Role of immortalized hepatocyte transplantation in acute liver failure. Transplant Proc 33:645-646
50. Kazuki Y, Oshimura M (2011) Human artifi-cial chromosomes for gene delivery and the development of animal models. Mol Ther 19:1591-1601
51. Zahler MH, Irani A, Malhi H et al (2000) The application of a lentiviral vector for gene transfer in fetal human hepatocytes. J Gene Med 2:186-193
52. Kobayashi N, Noguchi H, Fujiwara T et al (2000) Establishment of a highly differentiated immortalized adult human hepatocyte cell line by retroviral gene transfer. Transplant Proc 32:2368-2369
53. Nguyen TH, Oberholzer J, Birraux J et al (2002) Highly effi cient lentiviral vectormediated transduction of nondividing, fully reimplantable primary hepatocytes. Mol Ther 6:199-209
54. Ohashi K, Park F, Kay MA (2001) Hepatocyte transplantation: clinical and experimental application. J Mol Med 79:617-630
55. Pages JC, Andreoletti M, Bennoun M et al (1995) Effi cient retroviral-mediated gene transfer into primary culture of murine and human hepatocytes: expression of the LDL receptor. Hum Gene Ther 6:21-30
56. Selden C, Mellor N, Rees M et al (2007) Growth factors improve gene expression after lentiviral transduction in human adult and fetal hepatocytes. J Gene Med 9:67-76
57. Zamule SM, Strom SC, Omiecinski CJ (2008) Preservation of hepatic phenotype in lentiviral-transduced primary human hepatocytes. Chem Biol Interact 173:179-186
58. Ito M, Ito R, Yoshihara D et al (2008) Immortalized hepatocytes using human artifi-cial chromosome. Cell Transplant 17: 165-171
59. Ito M, Ikeno M, Nagata H et al (2009) Treatment of nonalbumin rats by transplantation of immortalized hepatocytes using artifi-cial human chromosome. Transplant Proc 41:422-424
60. Shitara S, Kakeda M, Nagata K et al (2008) Telomerase-mediated life-span extension of human primary fi broblasts by human artifi cial chromosome (HAC) vector. Biochem Biophys Res Commun 369:807-811
61. Watanabe T, Shibata N, Westerman KA et al (2003) Establishment of immortalized human hepatic stellate scavenger cells to develop bioartifi cial livers. Transplantation 75:1873-1880
62. Inoue Y, Miyazaki M, Tsuji T et al (2001) Reactivation of liver-specifi c gene expression in an immortalized human hepatocyte cell line by introduction of the human HNF4alpha2 gene. Int J Mol Med 8:481-487
63. Soltanpour Y, Hilgendorf C, Ahlström MM et al (2012) Characterization of THLEImmortalized cytochrome P450 (P450) cell lines: gene expression background and relationship to P450-enzyme activity. Drug Metab Dispos 40:2054-2058
64. Kobayashi N, Kunieda T, Sakaguchi M et al (2003) Active expression of p21 facilitates differentiation of immortalized human hepatocytes. Transplant Proc 35:433-434
65. Kunieda T, Kobayashi N, Sakaguchi M et al (2002) Transduction of immortalized human hepatocytes with p21 to enhance differentiated phenotypes. Cell Transplant 11:421-428
66. Allen KJ, Reyes R, Demmler K et al (2000) Conditionally immortalized mouse hepatocytes for use in liver gene therapy. J Gastroenterol Hepatol 15:1325-1332
67. Fox IJ, Chowdhury NR, Gupta S et al (1995) Conditional immortalization of Gunn rat hepatocytes: an ex vivo model for evaluating methods for bilirubin-UDP-glucuronosyltransferase gene transfer. Hepatology 21:837-846
68. May T, Hauser H, Wirth D (2004) Transcriptional control of SV40 T-antigen expression allows a complete reversion of immortalization. Nucleic Acids Res 32: 5529-5538
69. Westerman KA, Leboulch P (1996) Reversibleimmortalization of mammalian cells mediated by retroviral transfer and site-specifi c recombination. Proc Natl Acad Sci U S A 93:8971-8976
70. Paillard F (1999) Reversible cell immortalization with the Cre-lox system. Hum Gene Ther 10:1597-1598
71. Kobayashi N, Noguchi H, Fujiwara T et al (2000) Establishment of a reversibly immortalized human hepatocyte cell line by using Cre/loxP site-specifi c recombination. Transplant Proc 32:1121-1122
72. Anastassiadis K, Rostovskaya M, Lubitz S et al (2010) Precise conditional immortalization of mouse cells using tetracycline-regulated SV40 large T-antigen. Genesis 48:220-232
73. Jazwa A, Florczyk U, Jozkowicz A et al (2013) Gene therapy on demand: site-specifi c regulation of gene therapy. Gene 525:229-238
74. Ikeda M, Kato N, Mizutani T et al (1997) Analysis of the cell tropism of HCV by using in vitro HCV-infected human lymphocytes and hepatocytes. J Hepatol 27:445-454
75. Kato N, Ikeda M, Mizutani T et al (1996) Replication of hepatitis C virus in cultured non-neoplastic human hepatocytes. Jpn J Cancer Res 87:787-792
76. Ikeda F, Dansako H, Nishimura G et al (2010) Amino acid substitutions of hepatitis C virus core protein are not associated with intracellular antiviral response to interferon-α in vitro . Liver Int 30:1324-1331
77. Raychoudhuri A, Shrivastava S, Steele R et al (2010) Hepatitis C virus infection impairs IRF-7 translocation and alpha interferon synthesis in immortalized human hepatocytes. J Virol 84:10991-10998
78. Raychoudhuri A, Shrivastava S, Steele R et al (2011) ISG56 and IFITM1 proteins inhibit hepatitis C virus replication. J Virol 85: 12881-12889
79. Triyatni M, Saunier B, Maruvada P et al (2002) Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry. J Virol 76: 9335-9344
80. Yu GY, He G, Li CY et al (2012) Hepatic expression of HCV RNA-dependent RNA polymerase triggers innate immune signaling and cytokine production. Mol Cell 48:313-321
81. Yu S, Chen J, Wu M et al (2010) Hepatitis B virus polymerase inhibits RIG-I-and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3. J Gen Virol 91:2080-2090
82. Brown JJ, Parashar B, Moshage H et al (2000) A long-term hepatitis B viremia model generated by transplanting non-tumorigenic immortalized human hepatocytes in Rag-2-defi cient mice. Hepatology 31:173-181
83. Heim D, Cornils K, Schulze K et al (2014) Retroviral insertional mutagenesis in telomerase-immortalized hepatocytes identifi es RIPK4 as novel tumor suppressor in human hepatocarcinogenesis. Oncogene. doi: 10.1038/onc.2013.551
84. Wege H, Heim D, Lütgehetmann M et al (2011) Forced activation of β-catenin signaling supports the transformation of hTERTimmortalized human fetal hepatocytes. Mol Cancer Res 9:1222-1231
85. Guller MC, Andre J, Legrand A et al (2009) c-Fos accelerates hepatocyte conversion to a fi broblastoid phenotype through ERKmediated upregulation of paxillin-Serine178 phosphorylation. Mol Carcinog 48:532-544
86. Guller M, Toualbi-Abed K, Legrand A et al (2008) c-fos overexpression increases the proliferation of human hepatocytes by stabilizing nuclear cyclin D1. World J Gastroenterol 14:6339-6346
87. De Gottardi A, Vinciguerra M, Sgroi A et al (2007) Microarray analyses and molecular profi ling of steatosis induction in immortalized human hepatocytes. Lab Invest 87: 792-806
88. Martel C, Allouche M, Esposti DD et al (2013) Glycogen synthase kinase 3-mediated voltage-dependent anion channel phosphorylation controls outer mitochondrial membrane permeability during lipid accumulation. Hepatology 57:93-102
89. Pien GC, Basner-Tschakarjan E, Hui DJ et al (2009) Capsid antigen presentation fl ags human hepatocytes for destruction after transduction by adeno-associated viral vectors. J Clin Invest 119:1688-1695
90. Finn JD, Hui D, Downey HD et al (2010) Proteasome inhibitors decrease AAV2 capsid derived peptide epitope presentation on MHC class I following transduction. Mol Ther 18:135-142
91. Martino AT, Basner-Tschakarjan E, Markusic DM et al (2013) Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specifi c CD8+ T cells. Blood 121:2224-2233
92. LeCluyse E, Sinz M, Hewitt N et al (2010) Cytochrome P450 Induction. In: Lu C, Li A (eds) Enzyme inhibition in drug discovery and development: the good and the bad. Wiley, Hoboken, pp 265-314
93. Rand AA, Rooney JP, Butt CM et al (2014) Cellular toxicity associated with exposure to perfl uorinated carboxylates (PFCAs) and their metabolic precursors. Chem Res Toxicol 27:42-50
94. Thompson RA, Isin EM, Li Y et al (2012) In vitro approach to assess the potential for risk of idiosyncratic adverse reactions caused by candidate drugs. Chem Res Toxicol 25:1616-1632
95. Dambach DM, Andrews BA, Moulin F (2005) New technologies and screening strategies for hepatotoxicity: use of in vitro models. Toxicol Pathol 33:17-26
96. Winter HK, Ehrlich VA, Grusch M et al (2008) Use of four new human-derived livercell lines for the detection of genotoxic compounds in the single-cell gel electrophoresis (SCGE) assay. Mutat Res 657:133-139
97. Mills JB, Rose KA, Sadagopan N et al (2004) Induction of drug metabolism enzymes and MDR1 using a novel human hepatocyte cell line. J Pharmacol Exp Ther 309:303-309
98. Wang B, Chen G, Mao Z et al (2012) Preparation and cellular uptake of PLGA particles loaded with lamivudine. Chin Sci Bull 57:3985-3993
99. Tsuruga Y, Kiyono T, Matsushita M et al (2008) Effect of intrasplenic transplantation of immortalized human hepatocytes in the treatment of acetaminophen-induced acute liver failure SCID mice. Transplant Proc 40:617-619
100. Willberg CB, Ward SM, Clayton RF et al (2007) Protection of hepatocytes from cytotoxic T cell mediated killing by interferonalpha. PLoS One 2:e791
101. Ho L, Titus AS, Banerjee KK et al (2013) SIRT4 regulates ATP homeostasis and mediates a retrograde signaling via AMPK. Aging 5:835-849
102. Wargent ET, Zaibi MS, Silvestri C et al (2013) The cannabinoid Δ(9)-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity. Nutr Diabetes 3:e68
103. Caron S, Huaman SC, Dehondt H et al (2013) Farnesoid X receptor inhibits the transcriptional activity of carbohydrate response element binding protein in human hepatocytes. Mol Cell Biol 33:2202-2211
104. Lauressergues E, Bert E, Duriez P et al (2012) Does endoplasmic reticulum stress participate in APD-induced hepatic metabolic dysregulation? Neuropharmacology 62:784-796
105. Lasfer M, Vadrot N, Aoudjehane L et al (2008) Cadmium induces mitochondriadependent apoptosis of normal human hepatocytes. Cell Biol Toxicol 24:55-62
106. Kato N, Ikeda M, Sugiyama K et al (1998) Hepatitis C virus population dynamics in human lymphocytes and hepatocytes infected in vitro . J Gen Virol 79:1859-1869
107. Ikeda M, Nozaki A, Sugiyama K et al (2000) Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells. Virus Res 66:51-63
108. Suzuki K, Aoki K, Ohnami S et al (2003) Adenovirus-mediated gene transfer of interferon alpha inhibits hepatitis C virus replication in hepatocytes. Biochem Biophys Res Commun 307:814-819
109. Ikeda M, Sugiyama K, Mizutani T et al (1998) Human hepatocyte clonal cell lines that support persistent replication of hepatitis C virus. Virus Res 56:157-167
110. Tsuchihara K, Tanaka T, Hijikata M et al (1997) Specifi c interaction of polypyrimidine tract-binding protein with the extreme 3′-terminal structure of the hepatitis C virus genome, the 3′X. J Virol 71:6720-6726
111. Cuconati A, Mills C, Goddard C et al (2013) Suppression of AKT anti-apoptotic signaling by a novel drug candidate results in growth arrest and apoptosis of hepatocellular carcinoma cells. PLoS One 8:e54595
112. Brockhausen J, Tay SS, Grzelak CA et al (2014) miR-181a mediates TGF-β-induced hepatocyte EMT and is dysregulated in cir-rhosis and hepatocellular cancer. Liver Int. doi: 10.1111/liv.12517
113. Wilson R, Warner N, Ryan K et al (2011) The hepatitis B e antigen suppresses IL-1β-mediated NF-κB activation in hepatocytes. J Viral Hepat 18:e499-e507
114. Shah F, Louise-May S, Greene N (2014) Chemotypes sensitivity and predictivity of in vivo outcomes for cytotoxic assays in THLE and HepG2 cell lines. Bioorg Med Chem Lett 24:2753-2757
115. Gustafsson F, Foster AJ, Sarda S et al (2014) A correlation between the in vitro drug toxicity of drugs to cell lines that express human P450s and their propensity to cause liver injury in humans. Toxicol Sci 137:189-211
116. Rodrigues AV, Rollison HE, Martin S et al (2013) In vitro exploration of potential mechanisms of toxicity of the human hepatotoxic drug fenclozic acid. Arch Toxicol 87:1569-1579
117. Foster AJ, Prime LH, Gustafsson F et al (2013) Bioactivation of the cannabinoid receptor antagonist rimonabant to a cytotoxic iminium ion metabolite. Chem Res Toxicol 26:124-135
118. Antolino-Lobo I, Meulenbelt J, Nijmeijer SM et al (2010) Differential roles of phase I and phase II enzymes in 3,4-methylendioxymethamphetamine-induced cytotoxicity. Drug Metab Dispos 38:1105-1112
119. Saha S, New LS, Ho HK et al (2010) Direct toxicity effects of sulfo-conjugated troglitazone on human hepatocytes. Toxicol Lett 195:135-141
120. Saha S, New LS, Ho HK et al (2010) Investigation of the role of the thiazolidinedione ring of troglitazone in inducing hepatotoxicity. Toxicol Lett 192:141-149
121. Ip BC, Hu KQ, Liu C et al (2013) Lycopene metabolite, apo-10′-lycopenoic acid, inhibits diethylnitrosamine-initiated, high fat dietpromoted hepatic infl ammation and tumorigenesis in mice. Cancer Prev Res 6:1304-1316
122. Krajka-Kuzniak V, Paluszczak J, Oszmianski J et al (2014) Hawthorn (Crataegus oxyacantha L) bark extract regulates antioxidant response element (ARE)-mediated enzyme expression via Nrf2 pathway activation in normal hepatocyte cell line. Phytother Res 28:593-602
123. Krajka-Kuzniak V, Paluszczak J, Celewicz L et al (2013) Phloretamide, an apple phenolic compound, activates the Nrf2/ARE pathway in human hepatocytes. Food Chem Toxicol 51:202-209
124. Krajka-Kuzniak V, Paluszczak J, Baer-Dubowska W (2013) Xanthohumol induces phase II enzymes via Nrf2 in human hepatocytes in vitro . Toxicol In Vitro 27:149-156
125. Ait-Goughoulte M, Kanda T, Meyer K et al (2008) Hepatitis C virus genotype 1a growth and induction of autophagy. J Virol 82:2241-2249
126. Kanda T, Basu A, Steele R et al (2006) Generation of infectious hepatitis C virus in immortalized human hepatocytes. J Virol 80:4633-4639
127. Kanda T, Steele R, Ray R et al (2007) Hepatitis C virus infection induces the beta interferon signaling pathway in immortalized human hepatocytes. J Virol 81:12375-12381
128. Basu A, Saito K, Meyer K et al (2006) Stellate cell apoptosis by a soluble mediator from immortalized human hepatocytes. Apoptosis 11:1391-1400
129. Mazumdar B, Meyer K, Ray R (2012) N-terminal region of gelsolin induces apoptosis of activated hepatic stellate cells by a caspase-dependent mechanism. PLoS One 7:e44461
130. Qiu C, Hanson E, Olivier E et al (2005) Differentiation of human embryonic stem cells into hematopoietic cells by coculture with human fetal liver cells recapitulates the globin switch that occurs early in development. Exp Hematol 33:1450-1458
131. Gao Y, Theng SS, Zhuo J et al (2014) FAT10, an ubiquitin-like protein, confers malignant properties in non-tumorigenic and tumorigenic cells. Carcinogenesis 35: 923-934
132. Wang Y, Toh HC, Chow P et al (2012) MicroRNA-224 is up-regulated in hepatocellular carcinoma through epigenetic mechanisms. FASEB J 26:3032-3041
133. Tomimaru Y, Xu CQ, Nambotin SB et al (2013) Loss of exon 4 in a human T-cell factor-4 isoform promotes hepatic tumourigenicity. Liver Int 33:1536-1548
134. Nonaka M, Tazuma S, Hyogo H et al (2008) Cytoprotective effect of tauroursodeoxycholate on hepatocyte apoptosis induced by peroxisome proliferator-activated receptor gamma ligand. J Gastroenterol Hepatol 23:e198-e206
135. Nakamura K, Yamagishi S, Yoshida T et al (2007) Hydrogen peroxide stimulates pigment epithelium-derived factor gene and protein expression in the human hepatocyte cell line OUMS-29. J Int Med Res 35:427-432
136. Shishido S, Koga H, Harada M et al (2003) Hydrogen peroxide overproduction in megamitochondria of troglitazone-treated human hepatocytes. Hepatology 37:136-147